OR WAIT null SECS
Cannuba has announced that it is collaborating with an independent scientific body on drugs from the UK on the launch of a medical cannabis working group.
Cannuba, a medical cannabis research and production firm, has announced that it is collaborating with an independent scientific body on drugs from the United Kingdom on the launch of a medical cannabis working group.
In a May 28, 2019 press release, Cannuba stated its participation in the Drug Science Cannabis Working Group, which was officially launched at the Drug Science annual reception in the House of Lords on May 22, 2019. The working group, which includes drug science experts, patient representatives, policy makers, and other industry partners, will develop approaches to improving patient access to medical cannabis in the UK.
“Cannuba is both honored and excited to be a part of the Drug Science Working Group. We will be working alongside leading industry professionals to assist with integral research,” said Rob James, CEO of Cannuba. “With the right due diligence in place, our aim is to help people all over the UK gain access to life-changing medical products. This is a unique and privileged opportunity and puts Cannuba at the very forefront of meaningful scientific research.”